Clinical Trial Update: Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Tx360 transnasal sphenopalatine ganglion block for chronic migraine has been completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Drugs mentioned

• Tx360

Snippet

Sponsor: Tian Medical Inc. | Conditions: Headache, Migraine | Phase 3 | Status: COMPLETED